Treatment of patients with squamous cell carcinoma of the anal canal in the lest 20 years in gastroenterology hospital;El tratamiento de los pacientes con carcinoma epidermoide del canal anal en los últimos 20 años en nuestro hospital

Acta Gastroenterologica Latinoamericana

Volumn 35, Issue 2, 2005, Pages 94-98

  Hui, Jer Hwang ^b,f   Bestani, Claudia ^b   Jiménez, René ^b   Masciángioli, Guillermo ^c   Gutiérrez, Alejandro ^c   Cartelli, Cristina ^d   Rafailovici, Luisa ^e   Barugel, Mario ^a   Rodríguez, Gabriela ^f   Méndez, Guillermo ^a  

^a Sección Oncología

^b Dto de Medicina   (Argentina)

^c HOSPITAL DE GASTROENTEROLOGÍA DR CARLOS BONORINO UDAONDO   (Argentina)

^d ALCCA   (Argentina)

^e Vidt Centro Medico   (Argentina)

^f Estadística ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANUS TUMOR; ARTICLE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 24944493565     PISSN: 03009033     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jemal A, Murry T, Samuels A, Gahfoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Eng C, Abbruzzese J, Minsky DB. Chemotherapy and radiation of anal canal cancer: the first approach. In: Kahlenberg MS, Thomas CR, eds. The multidisciplinary management of anal cancer. Surgical Oncology Clinics of North America 2004;13:309-320.
3. Boman BM, Moertel CG, O'Connell MJ, Scott M, Weiland LH, Beart RW, Gunderson LL, Spencer RJ. Carcinoma of the anal canal: a clinical and pathologic study of 188 cases. Cancer 1984;71:1736-1740.
4. Esiashvili N, Landry J, Matthews RH. Carcinoma of the anus: strategies in management. The Oncologist 2002;7:188-199.
5. AJCC Cancer Staging Handbook. American Joint Committee on Cancer Staging Manual. Greene FI et al, eds; 2002:139-144.
6. Kaplan EL, Meier E. Non Parametric estimation for incomplete observation. J Am Stat Assoc 1958;53:457-481.
7. Nigro ND, Vaitkevicius VK, Considine Jr B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;17:354-356.
8. Sischky B. The use of radiation therapy combined with chemotherapy in the management of squamous cell carcinoma of the anus and marginally resectable adenocarcinoma of the rectum. Int J Radiat Oncol Biol Phys 1985;11:1587-1593.
9. Flam MS, John MJ, Mowry PA, Lovalvo LJ, Ramalho LD, Wade J. Definitive combined modality therapy of carcinoma of the anus: a report of 30 cases including results of salvage therapy in patients with residual disease. Dis Colon Rectum 1987;30:495-502.
10. Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin c. Int J Radiat Oncol Biol Phys 1991;21:1115-1125.
11. Flam M, John M, Pajak TF, Petrelli N, Myerson R, Doggett S, Quivey J, Rotman M, Kerman H, Coia L, Murray K. Role of mitomycin in combination with fluorouracil and radiotherapy, and salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 1996;14:2537-2539.
12. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset JF, Gonzalez DG, Peiffert D, van Glabbeke M, Pierart M. Concomitant radiotherapy and chemotherapy is superior to radiotherpay alone in the treatment of locally advanced anal cancer: a phase III randomized trial of the European Organization. J Clin Oncol 1997;15:2040-2049.
13. UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin. Lancet 1997;348:1049-1054.
14. Bartelink H, Schellens JH, Verheij M. The combined use of radiotherapy and chemotherapy in the treatment of solid tumours. Eur J Cancer 2002;38:216-222.
15. Zak, M, Drobnik, J. Effects of cis-dichlorodiammineplatinum (II) on the post irradiation lethality in mice after irradiation with X-rays. Stahlenthrapie 1971;142:112-115.
16. Roca E, Milano C, Pennella E, Barugel M, Gualdrini U, Lumi M, González G, Sardi M, Fleischer I, Graciano A. Tratamiento médico de 44 pacientes con carcinoma del conducto anal. Medicina (Buenos Aires) 1995;55:243-248.
17. Salem PA, Habboubi N, Anaissie E, Brihi ER, Issa P, Abbas JS, Khalyl MF. Effectiveness of cisplatin in the treatment of anal squamous cell carcinoma. Cancer Treat Rep 1985;69:891-893.
18. Ajani JA, Carrasco CH, Jackson DE, Wallace S. Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal. Am J Med 1989;87:221-224.
19. Rich TA, Ajani JA, Morrison WH, Ota D, Levin B. Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother Oncol 1993;27:209-215.
20. Hung A, Crane C, Delclos M, Ballo M, Ajani J, Lin E, Feig B, Skibber J, Janjan N. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index. Cancer 2003;97:1195-1202.
21. Roca E, Carraro S, Castillo Odena MS, Cartelli C, Rafailovici L, Chacón C, Lougedo M, Barugel M, Giannone C. Esquema ambulatorio con cisplatino, 5-FU y leucovorina, más radioterapia concurrente, en pacientes con carcinomas del conducto anal. Oncología Clínica 2002;7:760 (abstract 22).